Yazar "Erbasan, Vefa" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Comparison of clinical and biochemical features between bipolar patients on mood stabilizer alone or combination treatment(ELSEVIER, 2019) Erbasan, Vefa; Altınbaş, Kürşat[Abstract not Available]Öğe Comparison of inflammatory markers between patients with the first episode psychosis and bipolar mania(ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2018) Tekdemir, Rukiye; Bozkurt, Hazan Tomar; İmre, Okan; Erbasan, Vefa; Aydın, Memduha; Altınbaş, Kürşat[Abstract not Available]Öğe Is metabolic profile of the patients with first episode mania and psychotic disorder different?(ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2018) Bozkurt, Hazan Tomar; Tekdemir, Rukiye; Erbasan, Vefa; İmre, Okan; Aydın, Memduha; Altınbaş, Kürşat[Abstract not Available]Öğe Lityuma tedavi yanıtının klinik, biyolojik ve genetik yordayıcıları(2018) Bozkurt, Hazan Tomar; Erbasan, Vefa; Eğilmez, Ümran; Şen, Barış; Aydın, Memduha; Altınbaş, KürşatLityum, 1800’lü yılların basında İsveçli Arfvedson tarafından kesfedilmisve 1950’li yıllarda psikiyatrialanında kullanılmaya başlanmıştır. Yetişkinlerde bipolar tedavisinde ilk sırada gelen bir duygudurumdüzenleyici ve altın standart bir tedavi ajanıdır. Ancak, klinik uygulamada bireyler arasındalityum tedavisine yanıt oranları hastaların farklı özellikleri nedeniyle oldukça değişken olup, hangihastanın lityuma iyi yanıt vereceğini öngörmek çoğunlukla zordur. Lityum tedavi yanıtını öngörmedeklinisyenler öncelikle klinik bir fenotipi tanımaya odaklanmış gibi durmaktadır. Bu yazıda lityumtedavi yanıtının yordayıcıları ile ilgili araştırmalar gözden geçirilerek; klinik, biyokimyasal, nörogörüntülemeve genetik yordayıcılar olmak üzere dört başlık altında elealınmıştır.Öğe Suicide attempts and related factors in schizophrenia patients(SAUDI MED J, 2019) Aydın, Memduha; İlhan, Bilge Ç.; Tekdemir, Rukiye; Çokünlü, Yusuf; Erbasan, Vefa; Altınbaş, KürşatObjectives: To investigate the relationship between suicide attempts and demographic-clinical variables and to assess the methods used in suicide attempts by comparing schizophrenia patients with and without suicide attempts. Methods: A retrospective study with a total of 223 schizophrenia patients aged 18-65 years that were admitted to the Department of Psychiatry, Selcuk University and the Beyhekim Psychiatric Clinic Konya Training and Research Hospital, Konya, Turkey, between January 2014 and January 2018 The data collection forms created by researchers were completed using hospital medical records. Results: It was determined that 40.8% of schizophrenia patients attempted suicide at least once and that 39.6% of schizophrenia patients who attempted suicide had recurrent suicide attempts. Those with suicide attempts had a significantly longer mean duration of untreated psychosis and a higher total number of hospitalizations compared to those without suicide attempts. In addition, the use of depot antipsychotic drugs was significantly lower in those with suicide attempts. There was a statistically significant difference in the presence of traumatic life events between those with and without suicide attempts. Conclusion: Suicidal behavior is an important problem in schizophrenia. Identifying risk factors and high-risk individuals will guide us in the development of preventive interventions.